Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Xiaofang Bian
Special MTA: None
ATGGCCGGCGCTGCGCCGCGCCGCCTCGGCTGTGACGCTCTAATAGTCGTCGGCGGCTCC
GCTATGCCGCGCCGGGTTTTACACGTCCCCGTGCACGTTCGCGCCTGCAACCTCACCCAA
GAGCTATCGACGGGCGAGGACGCCCGCTTCTGTCGTCCGCGACCCGTTAACGTCGAACGG
GTGCGCGCTGTTTTTGCGGCTCTCTACCGTGCCTGTCCGATACACGTGAGGACCGAGCCC
GAGCGTGTCAAGCTGGTACTGGGTCGTCTGTTACTGGGACCCGTGGCCGTACCCTGTTTT
TGCGACGGTGAAGTGGAGGGCCACGGTGAACATCTGGTACCTACGACGCAGTTTTGTCGC
GGGCCGCTGCTCTACGTGCACCGACGTTGTTGTTGCGGATCCGTGACCGCCGGGCGCGCG
CTGTCCTACCACGTTCTCGAAAACCACGTGGCCACGCATGTGCTACGCGGATTGCTCTCG
CTGACGGAATGGAATCGAGAATTGCCGAGCCTCTTTTGCGACTGTCCTGGCGGCGGTGGC
GCCTCGGGAACCGAGGAACGCTACGCTATGGCCTGCCTGCCGCGCGACCTCAGCCTGCAC
CTGGACGACTATCCTTACCTGATGGTGGAAATCGGACGCGTACTCAGTGTCAGCGAGGTA
GACGACTACGTAACCGCCGTCTCCGGCTACCTGGGCGAGGCCGCGGCGCCGCGCATCCAG
GTTCACTACAAGCTGCTCTTTGGACTCAACGTGCGTCCGCAAGCGCCGTGCGCGTTGGAC
GCTACACGCGACTTTTTTCTGCTGGAGCTGCAAAAGCTTTGGCTGGGCGTTGAATATCAC
CACGAAGTGACGTCGGAGTTTTTCGGTCGCGTGCTGGCTCAGCTGCATCGCGACCGCGCC
CGCGTCATGATGGCGCTTCGCTTGCCCGAGCAGACGGTGTGCCACCTGAGCACCTTCGTT
CTCAGTCGCTTCAAGCGACAGGTACTGTACTTCAAGTTACAGGTGAGCTACGGCAAGTGC
CGGACTGGCCACGCTGACAGAAGTGGGGGAGGGGGAAACGGTGGAAATCAGGGACACCAC
AACCTACTGTGTTATCGACGCCTTAGCGTCACGTTTGCCGACACGGACACGGTGTGGAGA
AACCTTTTCTACGTTTATTATGAACTAGCTCGGGATCTGGGGTCCCATGGGACGGGGAAC
CGACCCGTAAACCGCGGTTACGGTGTTTCTTGCGCTCCGAGGACGTCGCGGCTATCACCG
TCAGAATCGACGGTGGTTTCGGCGAACGGACACGCGCTGTCTTCCACCGCGCTCCCGACG
ACGAGCGCGGGTCACAAGCTGTCACTGCCGCGCGACCCGGCCGCCGATCGCGTTCGACGT
TACGTGTGCATCATCTCGCGTCTCATGTACGCTCGGTACGGGGAGAGATGGCGTAAACAC
CGTCAACGGCGGTCGGAGACGGGAGAAGAGGAGGAGGAAGAGACGCTGGAATCGGGGGAG
ACTGACGCCACGCCGCCATTTGACTTTACGGGGCAGCAGCTGCGCCGGGCCTATCAGGAA
CACCGACGTCGTAAACATCTAGCCGTGCAGCGTTACGCGCCGTGCCGTCGTAAGCTCATC
GGCGGGATGGAGTTTGCCGAGGTGACGGGCGTGAGTCTGGACCGCATCGCCGTCAACGCT
TTCAACACCAACCGCGTTATCAATATGAAGGCCGCGCTCTCGTCCATCGCCGCGTCGGGT
CTCGGCGTGCGCGCGCCGCGGCTTCCCAAGAACATGACCCACAGTTTTGTGATGTACAAG
CACACCTTTAAGGAGCCCGCTTGCACCGTCAGCACCTTTGTTTCCAACGACGCCGTCTAC
ATCAACTCGCTCAACGTCAATATTCGCGGTTCCTACCCCGAGTTTCTGTACTCGCTGGGC
GTGTACCGGCTGCACGTTAATATCGATCACTTTTTTCTGCCGGCCGTGGTGTGCAACAGC
AACTCCTCGCTGGACGTGCATGGGCTGGAGGACCAGGCGGTGATCCGCTCGGAGCGCAGC
AAGGTGTACTGGACCACCAACTTTCCGTGCATGATCTCGCATACTAACAACGTCAACGTG
GGCTGGTTCAAAGCGGCTACGGCCATTGTGCCGCGCGTCTCGGGCGCTGACCTGGAAGCC
ATTCTGCTCAAAGAACTCTCGTGCATCAAGAACATGCGCGACGTGTGCATCGATTACGGT
CTGCACCGCGTTTTCACGCAACTAGAGCTGCGCAATTCGTACCAGATCCCCTTCCTGGCC
AAGCAGTTAGTGCTGTTTCTGCGTGCTTGCCTGCTCAAGCTGCACGGTCGAGAGAAGCGG
CTGCAGTTGGACCGCCTAGTATTTGAGGCGGCACAGCGGGGTCTCTTTGACTACAGCAAG
AACCTCACGGCGCACACCAAGATCAAGCACACTTGTGCGCTCATCGGCAGTCGTCTAGCC
AACAACGTGCCCAAGATCCTGGCCCGGAACAAAAAAGTCAAATTGGATCACCTGGGCCGG
AACGCCAACGTGCTGACGGTGTGTCGGCACGTGGAAGCCCACAAGATCCCTCGCACGCGC
CTCAAAGTGTTAGTCGAGGTGCTGGGCGTGTTGCAGAGTATCAGCGGTACGCCGCACACG
CGCGAAGTGATCCACCAGACGTTGTTTCGATTGTGCTCGGCGGCCGCAGCCACATCGGGC
CTGTGTTCATCCCCTCCCCCATTGTGTGTGTCCTCATCTTCCTCCGTCCCTTCTGTCCCA
ACCTCCGTCAGCGTTGACGGCAGTTCTGAACCCACGTCGCCGCGAGCGCGGTTTGCATCA
CGA
MAGAAPRRLGCDALIVVGGSAMPRRVLHVPVHVRACNLTQELSTGEDARFCRPRPVNVER VRAVFAALYRACPIHVRTEPERVKLVLGRLLLGPVAVPCFCDGEVEGHGEHLVPTTQFCR GPLLYVHRRCCCGSVTAGRALSYHVLENHVATHVLRGLLSLTEWNRELPSLFCDCPGGGG ASGTEERYAMACLPRDLSLHLDDYPYLMVEIGRVLSVSEVDDYVTAVSGYLGEAAAPRIQ VHYKLLFGLNVRPQAPCALDATRDFFLLELQKLWLGVEYHHEVTSEFFGRVLAQLHRDRA RVMMALRLPEQTVCHLSTFVLSRFKRQVLYFKLQVSYGKCRTGHADRSGGGGNGGNQGHH NLLCYRRLSVTFADTDTVWRNLFYVYYELARDLGSHGTGNRPVNRGYGVSCAPRTSRLSP SESTVVSANGHALSSTALPTTSAGHKLSLPRDPAADRVRRYVCIISRLMYARYGERWRKH RQRRSETGEEEEEETLESGETDATPPFDFTGQQLRRAYQEHRRRKHLAVQRYAPCRRKLI GGMEFAEVTGVSLDRIAVNAFNTNRVINMKAALSSIAASGLGVRAPRLPKNMTHSFVMYK HTFKEPACTVSTFVSNDAVYINSLNVNIRGSYPEFLYSLGVYRLHVNIDHFFLPAVVCNS NSSLDVHGLEDQAVIRSERSKVYWTTNFPCMISHTNNVNVGWFKAATAIVPRVSGADLEA ILLKELSCIKNMRDVCIDYGLHRVFTQLELRNSYQIPFLAKQLVLFLRACLLKLHGREKR LQLDRLVFEAAQRGLFDYSKNLTAHTKIKHTCALIGSRLANNVPKILARNKKVKLDHLGR NANVLTVCRHVEAHKIPRTRLKVLVEVLGVLQSISGTPHTREVIHQTLFRLCSAAAATSG LCSSPPPLCVSSSSSVPSVPTSVSVDGSSEPTSPRARFASR
Coding Sequence Details
Recommended Growth Condition: